U.S. to Require Drugmakers to Show Prices in TV Ads

(Reuters)—U.S. Centers for Medicare & Medicaid Services on Wednesday said it will require drugmakers to disclose the list price for their prescription drugs in direct-to-consumer television advertisements, part of the Trump administration’s efforts to lower costs for U.S. consumers. The list price should be included if it is equal to or greater than $35 for... [Read More]

Source: The Rheumatologist - May 9, 2019 Category: Rheumatology Authors: Reuters Staff Tags: Drug Updates Pharma Co. News drug price disclosure President Donald Trump's blueprint television advertisements U.S. Centers for Medicare & Medicaid Services Source Type: research